Healthcare -
Biotechnology - NASDAQ - US
$ 42.5681
0.355 %
$ 11.6 B
Market Cap
19.26
P/E
EXEL - NET INCOME
Net Income EXEL - Exelixis, Inc.
521 M
LAST VALUE
69.11%
2 YEAR CAGR
10.18%
5 YEAR CAGR
14.70%
10 YEAR CAGR